Thus, when an E/M service and a therapeutic and diagnostic Injection service are submitted with CMS Place of Service (POS) codes 19, 21, 22, 23, 24, 26, 51, 52, and 61 for the same patient by the Same Individual Physician or Other Qualified Health Care Professional on the same date of service, only the E/M service will be reimbursed and the therapeutic and diagnostic Injection(s) is not separately reimbursed, regardless of whether a modifier is reported with the Injection(s)
Apr 2014;101(4):941-4
et al., Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract , Current Pharmaceutical Design, 2011
Zinc levels in seminal plasma and their correlation with male infertility: A systematic review and meta-analysis
Instead, its turned out to be a disaster for reasons that arent likely to go away anytime soon
Not necessarily the semaglutide specifically, but across their product line